Immunocore Ltd
Clinical trials sponsored by Immunocore Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New targeted therapy shows promise for Hard-to-Treat cancers Results expected Oct 2026 (estimated)
- New bispecific drug targets Hard-to-Treat cancers in early trial Results expected Nov 2026 (estimated)